Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bioresorption and Vessel Wall Integration of a Fully Bioresorbable Polymeric Everolimus-Eluting Scaffold: Optical Coherence Tomography, Intravascular Ultrasound, and Histological Study in a Porcine Model With 4-Year Follow-Up.
Nakatani S, Ishibashi Y, Sotomi Y, Perkins L, Eggermont J, Grundeken MJ, Dijkstra J, Rapoza R, Virmani R, Serruys PW, Onuma Y. Nakatani S, et al. Among authors: rapoza r. JACC Cardiovasc Interv. 2016 Apr 25;9(8):838-851. doi: 10.1016/j.jcin.2016.01.030. JACC Cardiovasc Interv. 2016. PMID: 27101910 Free article.
Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial.
Onuma Y, Serruys PW, Perkins LE, Okamura T, Gonzalo N, García-García HM, Regar E, Kamberi M, Powers JC, Rapoza R, van Beusekom H, van der Giessen W, Virmani R. Onuma Y, et al. Among authors: rapoza r. Circulation. 2010 Nov 30;122(22):2288-300. doi: 10.1161/CIRCULATIONAHA.109.921528. Epub 2010 Oct 25. Circulation. 2010. PMID: 20975003
Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot results for future pre-clinical studies.
Gogas BD, Radu M, Onuma Y, Perkins L, Powers JC, Gomez-Lara J, Farooq V, Garcia-Garcia HM, Diletti R, Rapoza R, Virmani R, Serruys PW. Gogas BD, et al. Among authors: rapoza r. Int J Cardiovasc Imaging. 2012 Mar;28(3):499-511. doi: 10.1007/s10554-011-9860-z. Epub 2011 Apr 19. Int J Cardiovasc Imaging. 2012. PMID: 21503708 Free PMC article.
Effect of the endothelial shear stress patterns on neointimal proliferation following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography study.
Bourantas CV, Papafaklis MI, Kotsia A, Farooq V, Muramatsu T, Gomez-Lara J, Zhang YJ, Iqbal J, Kalatzis FG, Naka KK, Fotiadis DI, Dorange C, Wang J, Rapoza R, Garcia-Garcia HM, Onuma Y, Michalis LK, Serruys PW. Bourantas CV, et al. Among authors: rapoza r. JACC Cardiovasc Interv. 2014 Mar;7(3):315-24. doi: 10.1016/j.jcin.2013.05.034. Epub 2014 Feb 13. JACC Cardiovasc Interv. 2014. PMID: 24529931 Free article. Clinical Trial.
Vasomotor Function Comparative Assessment at 1 and 2 Years Following Implantation of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold and the Xience V Everolimus-Eluting Metallic Stent in Porcine Coronary Arteries: Insights From In Vivo Angiography, Ex Vivo Assessment, and Gene Analysis at the Stented/Scaffolded Segments and the Proximal and Distal Edges.
Gogas BD, Benham JJ, Hsu S, Sheehy A, Lefer DJ, Goodchild TT, Polhemus DJ, Bouchi YH, Hung OY, Yoo SY, Joshi U, Giddens DP, Veneziani A, Quyyumi A, Rapoza R, King SB 3rd, Samady H. Gogas BD, et al. Among authors: rapoza r. JACC Cardiovasc Interv. 2016 Apr 11;9(7):728-41. doi: 10.1016/j.jcin.2015.12.018. JACC Cardiovasc Interv. 2016. PMID: 27056313 Free article.
Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years.
Onuma Y, Honda Y, Asano T, Shiomi H, Kozuma K, Ozaki Y, Namiki A, Yasuda S, Ueno T, Ando K, Furuya J, Hanaoka KI, Tanabe K, Okada K, Kitahara H, Ono M, Kusano H, Rapoza R, Simonton C, Popma JJ, Stone GW, Fitzgerald PJ, Serruys PW, Kimura T. Onuma Y, et al. Among authors: rapoza r. JACC Cardiovasc Interv. 2020 Jan 13;13(1):116-127. doi: 10.1016/j.jcin.2019.09.047. JACC Cardiovasc Interv. 2020. PMID: 31918929 Free article. Clinical Trial.
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y, Serruys PW, Muramatsu T, Nakatani S, van Geuns RJ, de Bruyne B, Dudek D, Christiansen E, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Garcia-Garcia HM, Veldhof S, Rapoza R, Ormiston JA. Onuma Y, et al. Among authors: rapoza r. JACC Cardiovasc Interv. 2014 Dec;7(12):1400-11. doi: 10.1016/j.jcin.2014.06.016. JACC Cardiovasc Interv. 2014. PMID: 25523532 Free article. Clinical Trial.
Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine model.
Campos CM, Ishibashi Y, Eggermont J, Nakatani S, Cho YK, Dijkstra J, Reiber JH, Sheehy A, Lane J, Kamberi M, Rapoza R, Perkins L, Garcia-Garcia HM, Onuma Y, Serruys PW. Campos CM, et al. Among authors: rapoza r. Int J Cardiovasc Imaging. 2015 Mar;31(3):471-82. doi: 10.1007/s10554-015-0591-4. Epub 2015 Jan 28. Int J Cardiovasc Imaging. 2015. PMID: 25627777 Free PMC article.
77 results